FDA Investigating Burns From Zecuity Migraine Electrical Pain Patch

(June 6, 2016, 8:14 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on June 2 said it is investigating the risk of serious burns and potential permanent scarring caused by the Zecuity battery-operated migraine pain patch.

The FDA said that since Zecuity was marketed in September 2015, a “large number of patients have reported that they experienced burns or scars on the skin where the patch was worn.” The agency said the reports include descriptions of severe redness, pain, skin discoloration, blistering and cracked skin.

Zecuity is a transdermal...
To view the full article, register now.